menu search

Ayala pharmaceuticals reports financial results for the fiscal year ended october 31, 2022

REHOVOT, Israel and MONMOUTH JUNCTION, N.J., Feb. 10, 2023 (GLOBE NEWSWIRE) — Ayala Pharmaceuticals, Inc. (f/k/a Adv...

February 10, 2023, 12:00 pm

Ars pharmaceuticals to participate in the svb securities virtual global biopharma conference 2023

SAN DIEGO, Feb. 09, 2023 (GLOBE NEWSWIRE) — ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk pa...

February 9, 2023, 11:30 am

Are investors undervaluing axis capital holdings (axs) right now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Neverthe...

February 6, 2023, 11:17 am

axis capital to present at the bank of america financial services conference 2023

PEMBROKE, Bermuda--( BUSINESS WIRE )--axis Capital Holdings Limited (“...

February 3, 2023, 4:15 pm

Stereotaxis to report fourth quarter and full year 2022 financial results on march 3, 2023

ST. LOUIS, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in s...

February 2, 2023, 9:05 am

Has agnc investment (agnc) outpaced other finance stocks this year?

Here is how AGNC Investment (AGNC) and axis Capital (AXS) have performed compared to their sector so fa...

February 1, 2023, 11:18 am

Why axis capital (axs) is a great dividend stock right now

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does ...

January 31, 2023, 1:16 pm

Not expecting anything negative from the budget, says jinesh gopani, head of equities, axis asset management ltd

Not expecting anything negative from the Budget said Jinesh Gopani, Head of Equities, axis Asset Manage...

January 31, 2023, 3:14 am

Brokers digest: local equities – scientex bhd, axis real estate investment trust, dialog group bhd, kkb engineering bhd

This article first appeared in Capital, The Edge Malaysia Weekly on January 23, 2023 – January 29, 2023 UOB KAY HIAN RESEARCH (JAN 18): After three ...

January 30, 2023, 6:44 am

Elon musk faces sec probe for role in tesla self-driving claims

There is going to be some kind of reckoning around claims about 'self-driving' and robotaxis. Elon i...

January 27, 2023, 8:19 pm

Neuraxis seeks $15 million ipo for device expansion

Neuraxis, Inc. has filed proposed terms for a $15 million U.S. IPO. The firm is developing neuromodulat...

January 27, 2023, 3:08 pm

Astrazeneca's preventive covid therapy no longer effective against current variants

AstraZeneca AZN, -1.32% AZN, -1.54% said Thursday that the Food and Drug Administration is no longer allowing healthcare providers to prescribe Evushe...

January 26, 2023, 1:49 pm

axis capital holdings limited (axs) q4 2022 earnings call transcript

axis Capital Holdings Limited (NYSE:AXS ) Q4 2022 Earnings Conference Call January 26, 2023 9:30 AM ET ...

January 26, 2023, 12:26 pm

axis capital (axs) q4 earnings & revenues top estimates

axis Capital's (AXS) Q4 results reflected higher net premiums earned, partially offset by a decrease in...

January 26, 2023, 10:32 am

axis capital (axs) q4 earnings and revenues beat estimates

axis Capital (AXS) delivered earnings and revenue surprises of 14.71% and 6.43%, respectively, for the ...

January 25, 2023, 7:33 pm

Dr. reddy's laboratories limited (rdy) q3 2023 earnings call transcript

Dr. Reddy's Laboratories Limited (NYSE:RDY ) Q3 2023 Earnings Conference Call January 25, 2023 8:30 AM ET Company Participants Richa Periwal - IR Para...

January 25, 2023, 2:26 pm

Kalvista pharmaceuticals: the share price rally requires an adjustment of my investment thesis

KalVista intends to provide best-in-class therapies, both for acute on-demand and prophylaxis treatment...

January 25, 2023, 8:30 am

Exclusive: geely plans to turn maker of london black cabs into ev powerhouse

China's Geely is planning a big investment to turn the maker of London's iconic black taxis into a high...

January 23, 2023, 1:05 am

Arcutis presents new phase 2 long-term data showing sustained efficacy and clearance for a median of 10 months with roflumilast cream in adults with chronic plaque psoriasis

During the open label trial, 57.1% of roflumilast-treated participants achieved Investigator Global Assessment (IGA) of clear or almost clear at any t...

January 14, 2023, 9:00 am


Search within

Pages Search Results: